• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Tissue factor pathway inhibitor.

作者信息

Broze G J

机构信息

Jewish Hospital at Washington University, Department of Medicine, St. Louis, MO 63110, USA.

出版信息

Thromb Haemost. 1995 Jul;74(1):90-3.

PMID:8578532
Abstract
摘要

相似文献

1
Tissue factor pathway inhibitor.
Thromb Haemost. 1995 Jul;74(1):90-3.
2
The extrinsic pathway inhibitor: a regulator of tissue factor-dependent blood coagulation.
Thromb Haemost. 1991 Jul 12;66(1):6-15.
3
Structure and biology of tissue factor pathway inhibitor.组织因子途径抑制剂的结构与生物学特性
Thromb Haemost. 2001 Oct;86(4):959-72.
4
The tissue factor pathway: how it has become a "prima ballerina".
Thromb Haemost. 1995 Jul;74(1):7-17.
5
Regulation of the extrinsic pathway system in health and disease: the role of factor VIIa and tissue factor pathway inhibitor.健康与疾病状态下外源性凝血途径系统的调节：因子VIIa和组织因子途径抑制物的作用
Thromb Res. 1995 Jul 1;79(1):1-47. doi: 10.1016/0049-3848(95)00069-4.
6
[Tissue factor pathway inhibitor (TFPI) and its role in pathology].[组织因子途径抑制剂（TFPI）及其在病理学中的作用]
Postepy Hig Med Dosw. 1997;51(4):421-30.
7
The role of tissue factor pathway inhibitor in a revised coagulation cascade.组织因子途径抑制物在修正的凝血级联反应中的作用。
Semin Hematol. 1992 Jul;29(3):159-69.
8
Protease-activated receptors, apoptosis and tumor growth.蛋白酶激活受体、细胞凋亡与肿瘤生长。
Pathophysiol Haemost Thromb. 2008;36(3-4):137-47. doi: 10.1159/000175152. Epub 2009 Jan 27.
9
Pharmacological inhibition of tissue factor.
Semin Thromb Hemost. 2006 Feb;32(1):71-6. doi: 10.1055/s-2006-933342.
10
Tissue factor and tissue factor pathway inhibitor.组织因子与组织因子途径抑制物
Anaesthesia. 2004 May;59(5):483-92. doi: 10.1111/j.1365-2044.2004.03679.x.

引用本文的文献

1
Endothelial Glycocalyx: The Missing Link Between Angiogenic Imbalance in Preeclampsia and Systemic Inflammation in HELLP Syndrome.内皮糖萼：子痫前期血管生成失衡与HELLP综合征全身炎症之间的缺失环节
Compr Physiol. 2025 Aug;15(4):e70032. doi: 10.1002/cph4.70032.
2
Tissue factor pathway inhibitor-2 (TFPI-2)-an underappreciated partaker in cancer and metastasis.组织因子途径抑制剂-2（TFPI-2）——在癌症和转移中被低估的参与者。
Cancer Metastasis Rev. 2024 Dec;43(4):1185-1204. doi: 10.1007/s10555-024-10205-7. Epub 2024 Aug 17.
3
The Tissue Factor Pathway in Cancer: Overview and Role of Heparan Sulfate Proteoglycans.
癌症中的组织因子途径：硫酸乙酰肝素蛋白聚糖的概述及作用
Cancers (Basel). 2023 Feb 28;15(5):1524. doi: 10.3390/cancers15051524.
4
Management Strategies in Septic Coagulopathy: A Review of the Current Literature.脓毒症凝血病的管理策略：当前文献综述
Healthcare (Basel). 2023 Jan 12;11(2):227. doi: 10.3390/healthcare11020227.
5
Systematic Mendelian randomization using the human plasma proteome to discover potential therapeutic targets for stroke.利用人类血浆蛋白质组进行系统孟德尔随机化研究，以发现中风的潜在治疗靶点。
Nat Commun. 2022 Oct 17;13(1):6143. doi: 10.1038/s41467-022-33675-1.
6
The Composition and Physical Properties of Clots in COVID-19 Pathology.新冠病毒病理学中血栓的组成与物理特性
Diagnostics (Basel). 2022 Feb 24;12(3):580. doi: 10.3390/diagnostics12030580.
7
Imbalance in Coagulation/Fibrinolysis Inhibitors Resulting in Extravascular Thrombin Generation in Gliomas of Varying Levels of Malignancy.不同恶性程度脑胶质瘤中外源性凝血酶生成与凝血/纤溶抑制剂失衡的关系。
Biomolecules. 2021 Apr 29;11(5):663. doi: 10.3390/biom11050663.
8
Recent advances in use of fresh frozen plasma, cryoprecipitate, immunoglobulins, and clotting factors for transfusion support in patients with hematologic disease.血液疾病患者输血支持中新鲜冰冻血浆、冷沉淀、免疫球蛋白和凝血因子应用的最新进展。
Semin Hematol. 2020 Apr;57(2):73-82. doi: 10.1053/j.seminhematol.2020.07.006. Epub 2020 Jul 27.
9
Disseminated Intravascular Coagulation: An Update on Pathogenesis, Diagnosis, and Therapeutic Strategies.弥散性血管内凝血：发病机制、诊断和治疗策略的最新进展。
Clin Appl Thromb Hemost. 2018 Dec;24(9_suppl):8S-28S. doi: 10.1177/1076029618806424. Epub 2018 Oct 8.
10
The Journey of Protein S from an Anticoagulant to a Signaling Molecule.蛋白S从抗凝剂到信号分子的历程。
JSM Biochem Mol Biol. 2016;3(1). Epub 2016 Aug 8.